no news in this list.


We have established long-term partnerships with industry as well as several collaborations with leading academics in the disciplines that are relevant to the projects we support. We draw on the joint capabilities of this network to continuously improve our services and provide optimal assistance for each individual project at any time.

Industry Collaborations

TRION Pharma

  • Strategic collaboration for the development of drug candidates based on TRION Pharma’s Triomab® technology

Fresenius Biotech

  • Expert advice, preclinical and clinical services including logistics management supporting the development of Removab®, a trifunctional antibody for the treatment of malignant ascites (marketed in the EU since 2009)
  • Ongoing preclinical and clinical trial support for Removab® in various cancer indications
Academic Collaborations

BMBF-Project Biotechnology – BioChance: Identification of novel tumor markers

  • Department of Otorhinolaryngology University of Duisburg-Essen (PD Dr Sven Brandau)
  • „Westdeutsches Tumorzentrum Essen“, University of Duisburg-Essen (Prof. Dr W. Eberhardt)
  • Vaecgene Biotech GmbH

Spitzencluster m4, Project PM4: Performance of ‘Investigator-Initiated-Trials’ with Triomab® Antibodies (Removab® and Lymphomun®) as well as accompanying immunomonitoring in tumor therapy

  • III. Medical Clinic (hematology and oncology), Klinikum rechts der Isar, TU Munich (Prof. Dr C. Peschel)
  • Medical Clinic III, University Clinic Großhadern, LMU Munich (Dr R. Buhmann/ Prof. Dr. W. Hiddemann
  • Clinic Cologne-Merheim, University Witten-Herdecke (PD Dr Ströhlein/ Prof. Heiss)

EU FP7-Project: The SchistoVac (towards schistosomiasis therapy)

  • Research Center Borstel - Leibniz-Center for Medicine and Biosciences, Cellular Allergology (PD Dr H. Haas)